logo

ENSC

Ensysce Biosciences·NASDAQ
--
--(--)
--
--(--)

ENSC fundamentals

Ensysce Biosciences (ENSC) released its earnings on Aug 13, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.79 (YoY +76.06%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-0.79
+76.06%
Report date
Aug 13, 2025
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-10.8-127.8-81-10.8-43.2-923.4-31.2-14.7-13.05-16.95-8.25-3.31.05-2.9-1.39-0.79
Forecast
-127.816.2-28.8-30.6-28.8-76.15-27.8-15.85-13.05-13.5-5.851.05-2.735-3.015-1.015
Surprise
0.00%
0.00%
-600.00%
+62.50%
-41.18%
-3106.25%
+59.03%
+47.12%
+17.67%
-29.89%
+38.89%
+43.59%
0.00%
-6.03%
+53.90%
+22.17%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
400.00K1.20M1.00M600.00K200.00K300.00K800.00K495.00K420.00K505.00K305.00K200.00K3.41M1.30M1.31M--
Forecast
--1.20M800.00K1.20M1.00M1.00M950.00K760.00K593.33K395.00K400.00K300.00K3.40M245.00K0650.00K
Surprise
0.00%
0.00%
+25.00%
-50.00%
-80.00%
-70.00%
-15.79%
-34.87%
-29.21%
+27.85%
-23.75%
-33.33%
+0.29%
+430.61%
0.00%
0.00%

Earnings Call